Forewarned is forearmed: The cardiovascular time bomb in Cystic Fibrosis
CF clinical teams have borne witness to the population increases in CF and ageing CF population predicted across Europe [1]. This trend is set to continue with the advent of the highly effective CFTR modulators and CF teams are honing skills in managing diabetes, obesity and dyslipidaemia.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: J. Duckers, R. Fitzgerald, D. Proud, C. Addy, D. Datta Tags: Correspondence Source Type: research
More News: Cardiology | Cardiovascular | Cystic Fibrosis | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Obesity | Respiratory Medicine